Pancreatitis Trial, Recruiting NCT02775461 Sponsor: Icahn School of Medicine at Mount Sinai Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT02775461
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • You have at least one close family member (parent, sibling, or child) who has been diagnosed with pancreatic cancer
  • You carry a change (mutation) in one of these genes — BRCA1, BRCA2, PALB2, or ATM — AND have at least one family member with pancreatic cancer
  • You carry a mutation in the p16 or CDKN2A gene (a condition sometimes called Familial Atypical Multiple Mole Melanoma, or FAMMM) AND have at least one family member with pancreatic cancer
  • You are a known carrier of a change in the STK11 gene, which is linked to a condition called Peutz-Jeghers Syndrome
  • You have been diagnosed with Lynch Syndrome (also called HNPCC) AND have at least one family member with pancreatic cancer
  • You are a known carrier of a gene mutation linked to hereditary pancreatitis (an inherited condition causing repeated pancreas inflammation)
  • You have been told you have one or more fluid-filled sacs (cysts) on your pancreas of a specific type (called IPMNs) that are 1 centimetre or larger in size

Who may not be able to join:

  • You do not speak English or Spanish
  • You do not wish to participate
  • You are under 18 years of age

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aimee Lucas, MD, MS, Icahn School of Medicine at Mount Sinai

Phone: (212) 241-7269

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2013
Est. completion
1 January 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of individuals with pancreatic diseases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov